Pemetrexed

Pemetrexed (Alimta) is an antifolate chemotherapy drug used to treat a variety of cancers, including mesothelioma, non-small cell lung cancer, and ovarian cancer. It works by preventing cells from making the substances needed for their growth and survival, which stops the growth and spread of cancer cells. It is usually given through a vein (intravenously) and may be used alone or in combination with other chemotherapy drugs. Pemetrexed can cause severe side effects, including low white blood cell counts, nausea, vomiting, mouth sores, and hair loss.

Pemetrexed, also sold under the brand name Alimta, is an FDA-approved medication used to treat specific types of lung cancer. Here's a detailed breakdown of its function and key characteristics:

What it treats:

  • Pemetrexed is primarily used to treat non-small cell lung cancer (NSCLC), a common type of lung cancer. However, it's important to note that it's not effective for all NSCLC subtypes.
  • Pemetrexed is typically used in two main scenarios:
    • As monotherapy (single therapy): For the maintenance treatment of patients with locally advanced or metastatic NSCLC (cancer that has spread) whose disease hasn't worsened after initial platinum-based chemotherapy.
    • In combination with other chemotherapy medications: For the second-line treatment of patients with locally advanced or metastatic NSCLC.

How it Works:

  • Pemetrexed belongs to a class of medications called antifolates. These medications disrupt folate metabolism, which is essential for the rapid growth and replication of cancer cells. By interfering with folate pathways, pemetrexed hinders cancer cell proliferation and can lead to tumor shrinkage or growth slowdown.

Important Points to Remember:

  • Dosage and Administration: Pemetrexed is administered as an intravenous (IV) infusion into a vein over a period of 10 to 60 minutes. The dosage and treatment schedule depend on various factors, including your overall health, kidney function, and whether it's used as monotherapy or combination therapy. Your doctor will determine the most appropriate regimen for you.
  • Side Effects: Pemetrexed can cause side effects, some common and others more serious. Common side effects include fatigue, nausea and vomiting, mouth sores, loss of appetite, diarrhea, and low blood cell counts (which can increase your risk of infection). Serious side effects may include kidney problems, lung inflammation, and allergic reactions.
  • Not for Everyone: Pemetrexed is not suitable for everyone. People with severe kidney problems or compromised bone marrow function may not be good candidates for this medication. It's also not recommended during pregnancy or breastfeeding.

Additional Considerations:

  • Pemetrexed is a prescription medication and should only be taken under a doctor's supervision.
  • Before starting pemetrexed therapy, your doctor will perform blood tests to assess your overall health and suitability for this medication.
  • It's crucial to discuss the risks and benefits of pemetrexed with your doctor to determine if it's the right treatment option for your specific type of lung cancer and to understand the potential side effects.
  • Pemetrexed is often used in combination with other medications, and your doctor will develop a personalized treatment plan based on your individual needs.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01B - Antimetabolites
L01BA Folic acid analogues
External Links